Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Palisade Bio (PALI) EBT Margin (2016 - 2025)

Historic EBT Margin for Palisade Bio (PALI) over the last 14 years, with Q3 2025 value amounting to 58540.0%.

  • Palisade Bio's EBT Margin changed N/A to 58540.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 143350.0%, marking a year-over-year change of. This contributed to the annual value of 5234.0% for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Palisade Bio's EBT Margin is 58540.0%.
  • Palisade Bio's EBT Margin's 5-year high stood at 231100.0% during Q1 2025, with a 5-year trough of 1011.6% in Q1 2023.
  • In the last 3 years, Palisade Bio's EBT Margin had a median value of 11700.0% in 2021 and averaged 63986.98%.
  • The largest annual percentage gain for Palisade Bio's EBT Margin in the last 5 years was 851507600bps (2021), contrasted with its biggest fall of 331002500bps (2021).
  • Palisade Bio's EBT Margin (Quarter) stood at 11700.0% in 2021, then tumbled by -109bps to 1011.6% in 2023, then surged by 5887bps to 58540.0% in 2025.
  • Its last three reported values are 58540.0% in Q3 2025, 142250.0% for Q2 2025, and 231100.0% during Q1 2025.